Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose. [electronic resource]
Producer: 20120817Description: 1210-4 p. digitalISSN:- 1531-4995
- Administration, Intranasal
- Adult
- Aged
- Anesthesia, Local
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bevacizumab
- Drug Administration Schedule
- Epistaxis -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Injections, Intralesional
- Male
- Middle Aged
- Nasal Cavity -- anatomy & histology
- Nasal Mucosa -- drug effects
- Pilot Projects
- Premedication -- methods
- Preoperative Care -- methods
- Prospective Studies
- Recurrence
- Risk Assessment
- Severity of Illness Index
- Telangiectasia, Hereditary Hemorrhagic -- complications
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.